Ticker > Company >

Veerhealth Care share price

Veerhealth Care Ltd.

NSE: NIYATILEAS BSE: 511523 SECTOR: Pharmaceuticals & Drugs  18.4 K   16   1

18.40
-0.03 (-0.16%)
BSE: 12 Sep 04:01 PM

Price Summary

Today's High

₹ 19

Today's Low

₹ 18.1

52 Week High

₹ 25.2

52 Week Low

₹ 9.29

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

36.8 Cr.

Enterprise Value

36.56 Cr.

No. of Shares

2 Cr.

P/E

72.44

P/B

1.64

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  11.23

CASH

0.24 Cr.

DEBT

0 Cr.

Promoter Holding

31.5 %

EPS (TTM)

₹  0.25

Sales Growth

-0.38%

ROE

1.88 %

ROCE

5.96%

Profit Growth

-74.33 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-0.38%
3 Year7.72%
5 Year17.18%

Profit Growth

1 Year-72.73%
3 Year2.95%
5 Year21.2%

ROE%

1 Year1.88%
3 Year3.43%
5 Year3.08%

ROCE %

1 Year5.96%
3 Year4.82%
5 Year4.98%

Debt/Equity

0

Price to Cash Flow

12.71

Interest Cover Ratio

169.6053

CFO/PAT (5 Yr. Avg.)

1.7822741194487

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 31.50 0.00
Mar 2025 31.50 0.00
Dec 2024 30.41 0.00
Sep 2024 30.41 0.00
Jun 2024 30.41 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 80.5499 days.
  • Company has a healthy liquidity position with current ratio of 4.8528.
  • The company has a good cash flow management; CFO/PAT stands at 1.7822741194487.

 Limitations

  • The company has shown a poor profit growth of 2.31081720790525% for the Past 3 years.
  • The company has shown a poor revenue growth of 7.71744576760693% for the Past 3 years.
  • Company has a poor ROE of 3.43108913398372% over the past 3 years.
  • Company has a poor ROCE of 4.81646660386985% over the past 3 years
  • The company has a low EBITDA margin of 0.97965368412851% over the past 5 years.
  • The company is trading at a high PE of 72.44.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 2.06 5.15 3.84 5.62 4.49
Total Expenditure 2.08 4.66 3.69 5.79 4.52
Operating Profit -0.01 0.48 0.15 -0.17 -0.04
Other Income 0.36 0.25 0.18 0.43 0.65
Interest 0 0.11 0.01 0.14 0.1
Depreciation 0.19 0.2 0.25 0.27 0.28
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.15 0.42 0.07 -0.13 0.24
Tax 0.03 0.12 0 -0.03 0
Profit After Tax 0.12 0.3 0.07 -0.1 0.24
Adjusted EPS (Rs) 0.06 0.15 0.03 -0.05 0.12

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 11.73 10.58 9.63 13.27 13.22
Total Expenditure 11.05 10.64 10.46 12.78 12.61
Operating Profit 0.68 -0.06 -0.83 0.49 0.61
Other Income 0.48 1.33 1.68 1.25 1.39
Interest 0.19 0.22 0.09 0 0.01
Depreciation 0.32 0.47 0.52 0.62 0.71
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.65 0.58 0.24 1.12 1.28
Tax 0.33 0.2 0.31 -0.47 0.88
Net Profit 0.32 0.38 -0.07 1.52 0.41
Adjusted EPS (Rs.) 0.23 0.27 -0.05 0.79 0.2

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 6.93 6.93 6.93 10 20
Total Reserves 6.82 7.11 7.02 11.43 1.84
Borrowings 2.04 1.41 0 0 0
Other N/C liabilities 0.69 1.7 3.74 2.85 3.51
Current liabilities 1.49 1.58 2.46 0.97 2.77
Total Liabilities 17.98 18.73 20.15 25.25 28.12
Assets
Net Block 9.45 9.48 10.54 12.01 11.97
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 2.36 2.41 3.38 2.91 2.69
Other N/C Assets 0 0 0 0 0
Current Assets 6.18 6.84 6.23 10.34 13.46
Total Assets 17.98 18.73 20.15 25.25 28.12
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.65 0.47 0.26 1.05 1.29
Adjustment 0.21 0.37 0.1 0.53 0.47
Changes in Assets & Liabilities -1.15 0.39 1.49 -2.08 1.42
Tax Paid -0.06 -0.23 -0.04 -0.2 -0.28
Operating Cash Flow -0.36 1 1.81 -0.7 2.9
Investing Cash Flow -1.67 -0.09 -1.09 -1.79 -0.28
Financing Cash Flow 1.85 -0.83 -0.42 5.69 -5.99
Net Cash Flow -0.17 0.09 0.3 3.21 -3.37

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 30.41 30.41 30.41 31.50 31.50
ashish jayant shah 0.25 0.25 0.25 0.25 0.25
bhavin satish shah 0.87 0.87 0.87 0.87 0.87
bhavin satish shah huf . 0.82 0.82 0.82 0.82 0.82
dharnendra bipinchandra s... 0.06 0.06 0.06 0.06 0.05
divyabala m shah 1.20 1.20 1.20 1.20 1.20
jayant seventilal shah 0.06 0.06 0.06 0.06 0.06
jigar jayant shah 0.26 0.26 0.26 0.26 0.26
kalpana dharnendra shah 1.97 1.97 1.97 0.22 0.22
krupa harsh jain 1.11 1.11 1.11 3.95 3.95
mahasuklal shah huf 1.08 1.08 1.08 1.08 1.08
nisha bhavin shah 0.90 0.90 0.90 0.90 0.90
ruchi yogesh shah 3.33 3.33 3.33 3.33 3.33
shruti akash shah 3.29 3.29 3.29 3.29 3.29
yogesh mahasuklal shah 11.03 11.03 11.03 11.03 11.03
yogesh shah huf 4.21 4.21 4.21 4.21 4.21
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 69.59 69.59 69.59 68.50 68.50
bharat taparia 1.00 - - - 1.00
deval nilay shah 2.68 2.68 2.68 2.68 2.68
llp 0.19 0.09 0.01 - 0.06
samir . mehta - 1.26 1.83 1.99 1.99
veerhealth care limited s... 1.01 1.01 - - 1.00
hardik indramal jain - 1.10 1.10 - -
aryaman taparia 1.15 - - - -
jayakrishna taparia 2.27 - - - -
sourabh soni 1.37 - - - -
umang mahendra shah 3.12 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q3FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q1FY25

Company News

Veerhealth Care informs about press release 22 Aug, 4:53 PM Veerhealth Care - Quaterly Results 12 Aug, 5:17 PM Veerhealth Care - Quaterly Results 12 Aug, 5:17 PM Veerhealth Care - Quaterly Results 12 Aug, 5:17 PM Veerhealth Care secures order to manufacture, supply hair care products 7 Aug, 12:08 PM Veerhealth Care gets nod to manufacture, supply personal care products 24 Jul, 10:48 AM Veerhealth Care enters into contract manufacturing agreement with Leading Marketplace Company 9 Jul, 3:11 PM Veerhealth Care inks contract manufacturing agreement with leading marketplace company 7 Jul, 2:30 PM Veerhealth Care informs about press release 17 Jun, 5:08 PM Veerhealth Care’s Ayuveer brand completes onboarding process on Myntra 16 Jun, 2:41 PM Veerhealth Care - Quaterly Results 12 Feb, 4:59 PM Veerhealth Care - Quaterly Results 12 Feb, 4:59 PM Veerhealth Care informs about compliances-certificate 6 Jan, 4:55 PM Veerhealth Care informs about press release 19 Dec, 5:13 PM Veerhealth Care informs about press release 19 Dec, 4:59 PM Veerhealth Care introduces new marketing division of hospital care segment 18 Dec, 4:49 PM Veerhealth Care secures additional export order worth Rs 0.34 crore 13 Sep, 12:58 PM Veerhealth Care bags export order worth $40111 12 Sep, 3:28 PM Veerhealth Care informs about award of order 12 Sep, 12:15 PM Veerhealth Care - Quaterly Results 14 Aug, 5:15 PM Veerhealth Care - Quaterly Results 14 Aug, 5:15 PM Veerhealth Care bags export order for new toothpaste variant 12 Aug, 4:23 PM Veerhealth Care informs about press release 8 Aug, 4:43 PM Veerhealth Care purchases additional land in Gujarat 7 Aug, 10:13 AM Veerhealth Care informs about receipt of order 22 Jul, 12:51 PM Veerhealth Care bags order worth Rs 1.21 crore 22 Jul, 11:19 AM Veerhealth Care receives additional export order from Top US Institutional Supplier 15 Jul, 10:44 AM Veerhealth Care bags order worth Rs 89 lakh 12 Jul, 10:30 AM Veerhealth Care informs about transcripts of investor call 19 Jun, 2:33 PM Veerhealth Care’s brand ‘Ayuveer’ products now available on Nykaa for purchase 14 Jun, 6:11 PM Veerhealth Care informs about press release 17 May, 4:54 PM Veerhealth Care bags export order worth Rs 1.65 crore 15 May, 4:30 PM Veerhealth Care gets order worth Rs 57.36 lakh from Apollo Healthco 1 Apr, 5:08 PM Veerhealth Care informs about analyst meet 21 Mar, 4:43 PM Veerhealth Care informs about disclosure 26 Feb, 2:27 PM Veerhealth Care unveils ambitious expansion project to enhance healthcare solutions 22 Feb, 3:27 PM Veerhealth Care informs about press release 22 Feb, 12:31 PM Veerhealth Care - Quaterly Results 10 Feb, 4:19 PM Veerhealth Care - Quaterly Results 10 Feb, 4:19 PM Veerhealth Care - Quaterly Results 10 Feb, 4:19 PM Veerhealth Care informs about press release 2 Jan, 12:43 PM Veerhealth Care bags sample export order in USA 1 Jan, 5:56 PM Veerhealth Care bags order from F & G Branding 21 Nov, 4:58 PM Veerhealth Care - Quaterly Results 8 Nov, 5:18 PM Veerhealth Care informs about outcome of board meeting 25 Sep, 5:57 PM Veerhealth Care signs contract to supply ‘Whident’ range of toothpaste to North West Africa 12 Jun, 2:06 PM Veerhealth Care informs about new supply contract 12 Jun, 12:11 PM Veerhealth Care - Quaterly Results 22 May, 6:01 PM Veerhealth Care - Quaterly Results 22 May, 6:01 PM Veerhealth Care to introduce new product line ‘Disinfectant manufacturing’ 17 Apr, 3:52 PM

Veerhealth Care Stock Price Analysis and Quick Research Report. Is Veerhealth Care an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Veerhealth Care. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Veerhealth Care has a PE ratio of 72.4409448818898 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Veerhealth Care has ROA of 1.5218% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Veerhealth Care has a Current ratio of 4.8528.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Veerhealth Care has a ROE of 1.877%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Veerhealth Care has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Veerhealth Care has reported revenue growth of -0.3774% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Veerhealth Care for the current financial year is 4.61915421380602%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Veerhealth Care is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Veerhealth Care is Rs 0.254. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Veerhealth Care in Ticker for free. Also, one can get the intrinsic value of Veerhealth Care by using Valuation Calculators, which are available with a Finology ONE subscription. 

Veerhealth Care FAQs

Q1. What is Veerhealth Care share price today?
Ans: The current share price of Veerhealth Care is Rs 18.4.

Q2. What is the market capitalisation of Veerhealth Care?
Ans: Veerhealth Care has a market capitalisation of Rs 36.79719584 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Veerhealth Care?
Ans: The PE ratio of Veerhealth Care is 72.4409448818898 and the P/B ratio of Veerhealth Care is 1.63838085231421, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Veerhealth Care share?
Ans: The 52-week high share price of Veerhealth Care is Rs 25.2, and the 52-week low share price of Veerhealth Care is Rs 9.29.

Q5. Does Veerhealth Care pay dividends?
Ans: Currently, Veerhealth Care does not pay dividends. Dividend yield of Veerhealth Care is around 0%.

Q6. What are the face value and book value of Veerhealth Care shares?
Ans: The face value of Veerhealth Care shares is Rs 10, while the book value per share of Veerhealth Care is around Rs 11.2306. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Veerhealth Care?
Ans: Veerhealth Care has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Veerhealth Care?
Ans: The ROE of Veerhealth Care is 1.877% and ROCE of Veerhealth Care is 5.9577%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Veerhealth Care a good buy for the long term?
Ans: The Veerhealth Care long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Veerhealth Care undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Veerhealth Care appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Veerhealth Care’s financials?
Ans: You can review Veerhealth Care’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Veerhealth Care
X